563 related articles for article (PubMed ID: 24847908)
1. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction.
Zhang Z; Liang D; Gao X; Zhao C; Qin X; Xu Y; Su T; Sun D; Li W; Wang H; Liu B; Cao F
Basic Res Cardiol; 2014 Jul; 109(4):417. PubMed ID: 24847908
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways.
Zhang Z; Li S; Cui M; Gao X; Sun D; Qin X; Narsinh K; Li C; Jia H; Li C; Han Y; Wang H; Cao F
Basic Res Cardiol; 2013 Mar; 108(2):333. PubMed ID: 23386286
[TBL] [Abstract][Full Text] [Related]
3. Inositol pyrophosphates mediate the effects of aging on bone marrow mesenchymal stem cells by inhibiting Akt signaling.
Zhang Z; Zhao C; Liu B; Liang D; Qin X; Li X; Zhang R; Li C; Wang H; Sun D; Cao F
Stem Cell Res Ther; 2014 Mar; 5(2):33. PubMed ID: 24670364
[TBL] [Abstract][Full Text] [Related]
4. Autophagy mediates the beneficial effect of hypoxic preconditioning on bone marrow mesenchymal stem cells for the therapy of myocardial infarction.
Zhang Z; Yang C; Shen M; Yang M; Jin Z; Ding L; Jiang W; Yang J; Chen H; Cao F; Hu T
Stem Cell Res Ther; 2017 Apr; 8(1):89. PubMed ID: 28420436
[TBL] [Abstract][Full Text] [Related]
5. Transplantation of mesenchymal stem cells carrying the human receptor activity-modifying protein 1 gene improves cardiac function and inhibits neointimal proliferation in the carotid angioplasty and myocardial infarction rabbit model.
Shi B; Long X; Zhao R; Liu Z; Wang D; Xu G
Exp Biol Med (Maywood); 2014 Mar; 239(3):356-65. PubMed ID: 24477823
[TBL] [Abstract][Full Text] [Related]
6. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model.
Lim SY; Kim YS; Ahn Y; Jeong MH; Hong MH; Joo SY; Nam KI; Cho JG; Kang PM; Park JC
Cardiovasc Res; 2006 Jun; 70(3):530-42. PubMed ID: 16563361
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction.
Yao X; Liu Y; Gao J; Yang L; Mao D; Stefanitsch C; Li Y; Zhang J; Ou L; Kong D; Zhao Q; Li Z
Biomaterials; 2015 Aug; 60():130-40. PubMed ID: 25988728
[TBL] [Abstract][Full Text] [Related]
8. Enhanced mesenchymal cell engraftment by IGF-1 improves left ventricular function in rats undergoing myocardial infarction.
Enoki C; Otani H; Sato D; Okada T; Hattori R; Imamura H
Int J Cardiol; 2010 Jan; 138(1):9-18. PubMed ID: 19411121
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart.
Dakhlallah D; Zhang J; Yu L; Marsh CB; Angelos MG; Khan M
J Cardiovasc Pharmacol; 2015 Mar; 65(3):241-51. PubMed ID: 25658461
[TBL] [Abstract][Full Text] [Related]
10. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.
Huang J; Zhang Z; Guo J; Ni A; Deb A; Zhang L; Mirotsou M; Pratt RE; Dzau VJ
Circ Res; 2010 Jun; 106(11):1753-62. PubMed ID: 20378860
[TBL] [Abstract][Full Text] [Related]
11. Rosuvastatin treatment activates JAK-STAT pathway and increases efficacy of allogeneic mesenchymal stem cell transplantation in infarcted hearts.
Xu H; Yang YJ; Qian HY; Tang YD; Wang H; Zhang Q
Circ J; 2011; 75(6):1476-85. PubMed ID: 21502705
[TBL] [Abstract][Full Text] [Related]
12. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
[TBL] [Abstract][Full Text] [Related]
13. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium.
Pasha Z; Wang Y; Sheikh R; Zhang D; Zhao T; Ashraf M
Cardiovasc Res; 2008 Jan; 77(1):134-42. PubMed ID: 18006467
[TBL] [Abstract][Full Text] [Related]
14. Edaravone promotes activation of resident cardiac stem cells by transplanted mesenchymal stem cells in a rat myocardial infarction model.
Zhang GW; Gu TX; Sun XJ; Wang C; Qi X; Wang XB; Li-Ling J
J Thorac Cardiovasc Surg; 2016 Aug; 152(2):570-82. PubMed ID: 27056755
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of insulin-like growth factor 1 exerts a protective effect on hypoxic injury of aged BM-MSCs: role of autophagy.
Yang M; Wen T; Chen H; Deng J; Yang C; Zhang Z
Stem Cell Res Ther; 2018 Oct; 9(1):284. PubMed ID: 30359321
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation.
Noiseux N; Gnecchi M; Lopez-Ilasaca M; Zhang L; Solomon SD; Deb A; Dzau VJ; Pratt RE
Mol Ther; 2006 Dec; 14(6):840-50. PubMed ID: 16965940
[TBL] [Abstract][Full Text] [Related]
18. Angiogenic effects despite limited cell survival of bone marrow-derived mesenchymal stem cells under ischemia.
Hoffmann J; Glassford AJ; Doyle TC; Robbins RC; Schrepfer S; Pelletier MP
Thorac Cardiovasc Surg; 2010 Apr; 58(3):136-42. PubMed ID: 20379963
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway.
Chen JJ; Zhou SH
Cardiol J; 2011; 18(6):675-81. PubMed ID: 22113756
[TBL] [Abstract][Full Text] [Related]
20. Ghrelin improves functional survival of engrafted adipose-derived mesenchymal stem cells in ischemic heart through PI3K/Akt signaling pathway.
Han D; Huang W; Ma S; Chen J; Gao L; Liu T; Zhang R; Li X; Li C; Fan M; Chen Y; Cao F
Biomed Res Int; 2015; 2015():858349. PubMed ID: 25879037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
